![]() Intercept Pharmaceuticals Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases. | ![]() Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | ![]() Allergan Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products. | |
Founding Date | Founding Date 2002 | Founding Date 1996 | Founding Date 1948 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations New York, US HQ Wien, AT Mississauga, CA Kongens Lyngby, DK Paris, FR München, DE Dublin, IE see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Dublin, IE HQ Buenos Aires, AR Roseville, AU Machelen, BE Guarulhos, BR Las Condes, CL Bogotá, CO see more |
Employees | Employees 58321% increase | Employees 75,883 | Employees 10,5471% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) $285.7m (FY, 2022) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $984k (FY, 2022) | Cost of goods $8.4b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $284.7m (FY, 2022) | Gross profit $49.8b (FY, 2025) | Gross profit N/A |
Net income | Net income $221.8m (FY, 2022) | Net income $14b (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 55m | Total funding raised $ 6.5m | Total funding raised N/A |

Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company
Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products.
View company